Interpretation of Incidence Rates Data
Incidence Rate Report by State
Pancreas (Late Stage^), 2017-2021
All Races (includes Hispanic), Female, All Ages
Sorted by Count
Explanation of Column HeadersObjective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.
Other Notes
- Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
- Data is currently being suppressed if there are fewer than 16 counts for the time period.
Line by Line Interpretation of the Report
US (SEER+NPCR)1
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.5 to 8.6 and 18,700 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 72.0
Wyoming6
- Rate : The incidence rate is 7.2 with a 95% confidence interval from 6.0 to 8.6 and 27 average annual cases over 2017-2021.
- CI*Rank ⋔ : 46 (10, 50)
- Percent of Cases with Late Stage : 72.2
Alaska6
- Rate : The incidence rate is 7.8 with a 95% confidence interval from 6.6 to 9.3 and 29 average annual cases over 2017-2021.
- CI*Rank ⋔ : 36 (3, 50)
- Percent of Cases with Late Stage : 68.4
North Dakota6
- Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.1 to 9.5 and 39 average annual cases over 2017-2021.
- CI*Rank ⋔ : 32 (2, 49)
- Percent of Cases with Late Stage : 77.1
District of Columbia6
- Rate : The incidence rate is 10.9 with a 95% confidence interval from 9.5 to 12.6 and 41 average annual cases over 2017-2021.
- CI*Rank ⋔ : 1 (1, 22)
- Percent of Cases with Late Stage : 70.9
Vermont6
- Rate : The incidence rate is 9.0 with a 95% confidence interval from 7.8 to 10.3 and 44 average annual cases over 2017-2021.
- CI*Rank ⋔ : 16 (1, 46)
- Percent of Cases with Late Stage : 74.2
South Dakota6
- Rate : The incidence rate is 8.8 with a 95% confidence interval from 7.7 to 10.0 and 51 average annual cases over 2017-2021.
- CI*Rank ⋔ : 20 (1, 46)
- Percent of Cases with Late Stage : 76.0
Montana6
- Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.0 to 8.9 and 60 average annual cases over 2017-2021.
- CI*Rank ⋔ : 35 (9, 49)
- Percent of Cases with Late Stage : 71.9
Rhode Island6
- Rate : The incidence rate is 8.5 with a 95% confidence interval from 7.6 to 9.5 and 67 average annual cases over 2017-2021.
- CI*Rank ⋔ : 25 (2, 47)
- Percent of Cases with Late Stage : 73.8
Delaware6
- Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.0 to 10.0 and 68 average annual cases over 2017-2021.
- CI*Rank ⋔ : 15 (1, 43)
- Percent of Cases with Late Stage : 70.4
New Hampshire6
- Rate : The incidence rate is 8.4 with a 95% confidence interval from 7.6 to 9.2 and 84 average annual cases over 2017-2021.
- CI*Rank ⋔ : 29 (6, 47)
- Percent of Cases with Late Stage : 68.4
Maine6
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.0 to 8.5 and 88 average annual cases over 2017-2021.
- CI*Rank ⋔ : 39 (18, 49)
- Percent of Cases with Late Stage : 66.2
Hawaii3
- Rate : The incidence rate is 8.4 with a 95% confidence interval from 7.6 to 9.2 and 89 average annual cases over 2017-2021.
- CI*Rank ⋔ : 28 (5, 46)
- Percent of Cases with Late Stage : 71.4
New Mexico3
- Rate : The incidence rate is 6.2 with a 95% confidence interval from 5.6 to 6.8 and 93 average annual cases over 2017-2021.
- CI*Rank ⋔ : 50 (46, 50)
- Percent of Cases with Late Stage : 61.0
Nebraska6
- Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.1 to 8.5 and 97 average annual cases over 2017-2021.
- CI*Rank ⋔ : 38 (18, 49)
- Percent of Cases with Late Stage : 68.3
Idaho3
- Rate : The incidence rate is 8.7 with a 95% confidence interval from 8.0 to 9.6 and 99 average annual cases over 2017-2021.
- CI*Rank ⋔ : 21 (3, 41)
- Percent of Cases with Late Stage : 74.9
Puerto Rico6
- Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.8 to 4.5 and 103 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 58.1
Utah3
- Rate : The incidence rate is 7.0 with a 95% confidence interval from 6.4 to 7.6 and 104 average annual cases over 2017-2021.
- CI*Rank ⋔ : 48 (35, 50)
- Percent of Cases with Late Stage : 70.4
West Virginia6
- Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.3 to 9.8 and 126 average annual cases over 2017-2021.
- CI*Rank ⋔ : 14 (2, 36)
- Percent of Cases with Late Stage : 74.9
Nevada6
- Rate : The incidence rate is 6.8 with a 95% confidence interval from 6.3 to 7.4 and 132 average annual cases over 2017-2021.
- CI*Rank ⋔ : 49 (39, 50)
- Percent of Cases with Late Stage : 62.1
Kansas6
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.1 to 8.2 and 148 average annual cases over 2017-2021.
- CI*Rank ⋔ : 41 (23, 48)
- Percent of Cases with Late Stage : 75.8
Arkansas6
- Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.1 to 8.2 and 159 average annual cases over 2017-2021.
- CI*Rank ⋔ : 42 (25, 48)
- Percent of Cases with Late Stage : 68.7
Mississippi6
- Rate : The incidence rate is 8.8 with a 95% confidence interval from 8.2 to 9.4 and 180 average annual cases over 2017-2021.
- CI*Rank ⋔ : 19 (5, 36)
- Percent of Cases with Late Stage : 72.3
Oklahoma6
- Rate : The incidence rate is 7.8 with a 95% confidence interval from 7.3 to 8.3 and 200 average annual cases over 2017-2021.
- CI*Rank ⋔ : 37 (24, 47)
- Percent of Cases with Late Stage : 70.3
Iowa3
- Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.6 to 9.8 and 205 average annual cases over 2017-2021.
- CI*Rank ⋔ : 11 (2, 30)
- Percent of Cases with Late Stage : 76.5
Oregon6
- Rate : The incidence rate is 8.3 with a 95% confidence interval from 7.8 to 8.8 and 246 average annual cases over 2017-2021.
- CI*Rank ⋔ : 30 (14, 41)
- Percent of Cases with Late Stage : 71.5
Alabama6
- Rate : The incidence rate is 7.0 with a 95% confidence interval from 6.6 to 7.4 and 250 average annual cases over 2017-2021.
- CI*Rank ⋔ : 47 (40, 50)
- Percent of Cases with Late Stage : 60.9
Colorado6
- Rate : The incidence rate is 7.4 with a 95% confidence interval from 7.0 to 7.8 and 251 average annual cases over 2017-2021.
- CI*Rank ⋔ : 44 (33, 49)
- Percent of Cases with Late Stage : 70.8
Connecticut3
- Rate : The incidence rate is 10.0 with a 95% confidence interval from 9.5 to 10.6 and 264 average annual cases over 2017-2021.
- CI*Rank ⋔ : 2 (1, 14)
- Percent of Cases with Late Stage : 76.4
Kentucky3
- Rate : The incidence rate is 9.0 with a 95% confidence interval from 8.5 to 9.5 and 276 average annual cases over 2017-2021.
- CI*Rank ⋔ : 17 (5, 31)
- Percent of Cases with Late Stage : 73.8
Louisiana3
- Rate : The incidence rate is 10.0 with a 95% confidence interval from 9.5 to 10.5 and 306 average annual cases over 2017-2021.
- CI*Rank ⋔ : 3 (1, 12)
- Percent of Cases with Late Stage : 77.4
Minnesota6
- Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.8 to 8.6 and 308 average annual cases over 2017-2021.
- CI*Rank ⋔ : 33 (17, 41)
- Percent of Cases with Late Stage : 66.0
South Carolina6
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.1 to 9.0 and 316 average annual cases over 2017-2021.
- CI*Rank ⋔ : 23 (11, 37)
- Percent of Cases with Late Stage : 72.3
Tennessee6
- Rate : The incidence rate is 7.6 with a 95% confidence interval from 7.3 to 8.0 and 356 average annual cases over 2017-2021.
- CI*Rank ⋔ : 43 (30, 47)
- Percent of Cases with Late Stage : 66.5
Maryland6
- Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.1 to 9.0 and 360 average annual cases over 2017-2021.
- CI*Rank ⋔ : 24 (12, 36)
- Percent of Cases with Late Stage : 71.3
Arizona6
- Rate : The incidence rate is 7.3 with a 95% confidence interval from 7.0 to 7.7 and 361 average annual cases over 2017-2021.
- CI*Rank ⋔ : 45 (36, 49)
- Percent of Cases with Late Stage : 68.0
Missouri6
- Rate : The incidence rate is 8.5 with a 95% confidence interval from 8.1 to 8.9 and 365 average annual cases over 2017-2021.
- CI*Rank ⋔ : 26 (13, 37)
- Percent of Cases with Late Stage : 72.0
Wisconsin6
- Rate : The incidence rate is 8.9 with a 95% confidence interval from 8.5 to 9.3 and 367 average annual cases over 2017-2021.
- CI*Rank ⋔ : 18 (7, 31)
- Percent of Cases with Late Stage : 72.2
Virginia6
- Rate : The incidence rate is 7.7 with a 95% confidence interval from 7.3 to 8.0 and 439 average annual cases over 2017-2021.
- CI*Rank ⋔ : 40 (31, 47)
- Percent of Cases with Late Stage : 66.4
Washington5
- Rate : The incidence rate is 9.3 with a 95% confidence interval from 8.9 to 9.7 and 452 average annual cases over 2017-2021.
- CI*Rank ⋔ : 10 (3, 23)
- Percent of Cases with Late Stage : 76.0
Georgia3
- Rate : The incidence rate is 9.3 with a 95% confidence interval from 9.0 to 9.6 and 610 average annual cases over 2017-2021.
- CI*Rank ⋔ : 9 (3, 21)
- Percent of Cases with Late Stage : 76.8
New Jersey3
- Rate : The incidence rate is 9.9 with a 95% confidence interval from 9.5 to 10.2 and 647 average annual cases over 2017-2021.
- CI*Rank ⋔ : 4 (1, 10)
- Percent of Cases with Late Stage : 73.2
Michigan6
- Rate : The incidence rate is 9.1 with a 95% confidence interval from 8.8 to 9.5 and 652 average annual cases over 2017-2021.
- CI*Rank ⋔ : 12 (5, 23)
- Percent of Cases with Late Stage : 72.2
North Carolina6
- Rate : The incidence rate is 9.3 with a 95% confidence interval from 9.0 to 9.6 and 666 average annual cases over 2017-2021.
- CI*Rank ⋔ : 8 (3, 21)
- Percent of Cases with Late Stage : 75.4
Ohio6
- Rate : The incidence rate is 8.6 with a 95% confidence interval from 8.3 to 8.9 and 717 average annual cases over 2017-2021.
- CI*Rank ⋔ : 22 (14, 33)
- Percent of Cases with Late Stage : 70.8
Illinois3
- Rate : The incidence rate is 9.4 with a 95% confidence interval from 9.1 to 9.7 and 812 average annual cases over 2017-2021.
- CI*Rank ⋔ : 7 (3, 18)
- Percent of Cases with Late Stage : 73.9
Pennsylvania6
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.3 to 9.9 and 942 average annual cases over 2017-2021.
- CI*Rank ⋔ : 5 (2, 15)
- Percent of Cases with Late Stage : 73.5
Texas3
- Rate : The incidence rate is 8.0 with a 95% confidence interval from 7.8 to 8.2 and 1,262 average annual cases over 2017-2021.
- CI*Rank ⋔ : 34 (28, 41)
- Percent of Cases with Late Stage : 68.3
New York3
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.3 to 9.8 and 1,376 average annual cases over 2017-2021.
- CI*Rank ⋔ : 6 (2, 13)
- Percent of Cases with Late Stage : 75.3
Florida6
- Rate : The incidence rate is 8.4 with a 95% confidence interval from 8.2 to 8.6 and 1,459 average annual cases over 2017-2021.
- CI*Rank ⋔ : 27 (19, 34)
- Percent of Cases with Late Stage : 71.7
California3
- Rate : The incidence rate is 8.2 with a 95% confidence interval from 8.1 to 8.4 and 1,993 average annual cases over 2017-2021.
- CI*Rank ⋔ : 31 (23, 37)
- Percent of Cases with Late Stage : 74.0
- Rate : Data not available for this combination of data selections.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/06/2024 2:59 pm.
State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.
^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).
Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.